Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, NY 10021, USA.
Arthritis Res Ther. 2011 Jul 28;13(4):234. doi: 10.1186/ar3379.
Bone remodeling in physiological and pathological conditions represents a balance between bone resorption mediated by osteoclasts and bone formation by osteoblasts. Bone resorption is tightly and dynamically regulated by multiple mediators, including cytokines that act directly on osteoclasts and their precursors, or indirectly by modulating osteoblast lineage cells that in turn regulate osteoclast differentiation. The critical role of cytokines in inducing and promoting osteoclast differentiation, function and survival is covered by the accompanying review by Zwerina and colleagues. Recently, it has become clear that negative regulation of osteoclastogenesis and bone resorption by inflammatory factors and cytokines, downstream signaling pathways, and a newly described network of transcriptional repressors plays a key role in bone homeostasis by fine tuning bone remodeling and restraining excessive bone resorption in inflammatory settings. In this review we discuss negative regulators of osteoclastogenesis and mechanisms by which these factors suppress bone resorption.
在生理和病理条件下,骨重塑代表了破骨细胞介导的骨吸收与成骨细胞介导的骨形成之间的平衡。骨吸收受到多种介质的紧密和动态调节,包括直接作用于破骨细胞及其前体细胞的细胞因子,或通过间接调节成骨细胞系细胞来调节破骨细胞分化。Zwerina 及其同事的相关综述涵盖了细胞因子在诱导和促进破骨细胞分化、功能和存活中的关键作用。最近,炎症因子和细胞因子、下游信号通路以及新描述的转录抑制因子网络通过精细调节骨重塑和抑制炎症环境中过度的骨吸收,对破骨细胞生成和骨吸收的负向调节作用及其抑制骨吸收的机制,已变得非常清楚。在本综述中,我们讨论了破骨细胞生成的负向调节剂及其抑制骨吸收的机制。